Article Details

StockNews.com Begins Coverage on ContraFect (NASDAQ:CFRX) - The AM Reporter

Retrieved on: 2022-11-20 08:15:34

Tags for this article:

Click the tags to see associated articles and topics

StockNews.com Begins Coverage on ContraFect (NASDAQ:CFRX) - The AM Reporter. View article details on hiswai:

Excerpt

The brokerage set a “sell” rating on the biotechnology company's stock. ContraFect Trading Down 6.8 %. Shares of CFRX stock opened at $0.14 on Friday.

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up